BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33165359)

  • 1. A Clinicohistopathological Analysis of Cutaneous Fibrous Histiocytomas of the Finger.
    Nam KH; Park SW; Yun SK
    Indian J Dermatol; 2020; 65(5):401-405. PubMed ID: 33165359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digital dermatofibromas--common lesion, uncommon location: a series of 26 cases and review of the literature.
    Lehmer LM; Ragsdale BD
    Dermatol Online J; 2011 Aug; 17(8):2. PubMed ID: 21906482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cellular fibrous histiocytoma: a clinicopathologic analysis of 27 cases].
    Zhong YP; Wang J
    Zhonghua Bing Li Xue Za Zhi; 2013 Mar; 42(3):153-7. PubMed ID: 23769432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High proliferative activity excludes dermatofibroma: report of the utility of MIB-1 in the differential diagnosis of selected fibrohistiocytic tumors.
    Hanly AJ; Jordà M; Elgart GW; Badiavas E; Nassiri M; Nadji M
    Arch Pathol Lab Med; 2006 Jun; 130(6):831-4. PubMed ID: 16740036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Unusual Presentation of Epitheloid Dermatofibroma- Rare Case Report".
    Vasani A; Hirapara K; Vadher P
    Indian J Otolaryngol Head Neck Surg; 2024 Feb; 76(1):1157-1160. PubMed ID: 38440582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical expression of matrix metalloproteinases 1, 2, 9, and 14 in dermatofibrosarcoma protuberans and common fibrous histiocytoma (dermatofibroma).
    Weinrach DM; Wang KL; Wiley EL; Laskin WB
    Arch Pathol Lab Med; 2004 Oct; 128(10):1136-41. PubMed ID: 15387709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tenascin expression in cutaneous fibrohistiocytic tumors. Immunohistochemical investigation of 24 cases.
    Franchi A; Santucci M
    Am J Dermatopathol; 1996 Oct; 18(5):454-9. PubMed ID: 8902090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple cutaneous fibrous histiocytomas in association with systemic lupus erythematosus.
    Yamamoto T; Sumi K; Yokozeki H; Nishioka K
    J Dermatol; 2005 Aug; 32(8):645-9. PubMed ID: 16334865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular benign fibrous histiocytoma. Clinicopathologic analysis of 74 cases of a distinctive variant of cutaneous fibrous histiocytoma with frequent recurrence.
    Calonje E; Mentzel T; Fletcher CD
    Am J Surg Pathol; 1994 Jul; 18(7):668-76. PubMed ID: 8017561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dermatofibrosarcoma Darier and Ferrand. Immunohistochemistry study of 38 cases. Research on a specific marker].
    Declerck D; Claye C; Rotteleur G; Lecomte-Houcke M
    Ann Pathol; 1997 Oct; 17(5):324-8. PubMed ID: 9471146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of CD163 in dermatofibroma, cellular fibrous histiocytoma, and dermatofibrosarcoma protuberans: comparison with CD68, CD34, and Factor XIIIa.
    Sachdev R; Sundram U
    J Cutan Pathol; 2006 May; 33(5):353-60. PubMed ID: 16640542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The ultrastructure of fibrous and histiocytic skin tumors (dermatofibroma, dermatofibrosarcoma protuberans, fibroxanthoma, and histiocytoma) (author's transl)].
    Auböck L
    Virchows Arch A Pathol Anat Histol; 1975 Oct; 368(3):253-74. PubMed ID: 171831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcutaneous atypical fibrous histiocytoma.
    Garrido-Ruiz MC; Ramos P; Enguita AB; Rodriguez Peralto JL
    Am J Dermatopathol; 2009 Jul; 31(5):499-501. PubMed ID: 19542931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aneurysmal Variant of Fibrous Histiocytoma- A Rare Entity Known for Recurrence.
    Antony A; Kiran CM; Phansalkar M; Jothi C; Jayakar J
    J Clin Diagn Res; 2017 Jun; 11(6):ED08-ED09. PubMed ID: 28764178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benign fibrous histiocytoma (dermatofibroma) of the face: clinicopathologic and immunohistochemical study of 34 cases associated with an aggressive clinical course.
    Mentzel T; Kutzner H; Rütten A; Hügel H
    Am J Dermatopathol; 2001 Oct; 23(5):419-26. PubMed ID: 11801774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Features and Treatment of Fibrous Histiocytomas of the Tongue: A Systematic Review.
    Nguyen A; Vaudreuil A; Haun P; Caponetti G; Huerter C
    Int Arch Otorhinolaryngol; 2018 Jan; 22(1):94-102. PubMed ID: 29371905
    [No Abstract]   [Full Text] [Related]  

  • 17. Myxoid dermatofibrosarcoma protuberans: clinicopathologic, immunohistochemical, and molecular analysis of eight cases.
    Mentzel T; Schärer L; Kazakov DV; Michal M
    Am J Dermatopathol; 2007 Oct; 29(5):443-8. PubMed ID: 17890911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desmin and CD34 positivity in cellular fibrous histiocytoma: an immunohistochemical analysis of 100 cases.
    Volpicelli ER; Fletcher CD
    J Cutan Pathol; 2012 Aug; 39(8):747-52. PubMed ID: 22775584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA copy number changes in tumors within the spectrum of cellular, atypical, and metastasizing fibrous histiocytoma.
    Charli-Joseph Y; Saggini A; Doyle LA; Fletcher CD; Weier J; Mirza S; Vemula S; LeBoit PE
    J Am Acad Dermatol; 2014 Aug; 71(2):256-63. PubMed ID: 24755122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. INI1 and GLUT-1 expression in epithelioid sarcoma and its cutaneous neoplastic and nonneoplastic mimics.
    Orrock JM; Abbott JJ; Gibson LE; Folpe AL
    Am J Dermatopathol; 2009 Apr; 31(2):152-6. PubMed ID: 19318800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.